{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:27:51Z","timestamp":1762432071936,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Symmetry"],"abstract":"<jats:p>Chlorambucil (Chl), Melphalan (Mel), and Cytarabine (Cyt) are recognized drugs used in the chemotherapy of patients with advanced Chronic Lymphocytic Leukemia (CLL). The optimal treatment schedule and timing of Chl, Mel, and Cyt administration remains unknown and has traditionally been decided empirically and independently of preclinical in vitro efficacy studies. As a first step toward mathematical prediction of in vivo drug efficacy from in vitro cytotoxicity studies, we used murine A20 leukemic cells as a test case of CLL. We first found that logistic growth best described the proliferation of the cells in vitro. Then, we tested in vitro the cytotoxic efficacy of Chl, Mel, and Cyt against A20 cells. On the basis of these experimental data, we found the parameters for cancer cell death rates that were dependent on the concentration of the respective drugs and developed a mathematical model involving nonlinear ordinary differential equations. For the proposed mathematical model, three equilibrium states were analyzed using the general method of Lyapunov, with only one equilibrium being stable. We obtained a very good symmetry between the experimental results and numerical simulations of the model. Our novel model can be used as a general tool to study the cytotoxic activity of various drugs with different doses and modes of action by appropriate adjustment of the values for the selected parameters.<\/jats:p>","DOI":"10.3390\/sym13101760","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T22:50:48Z","timestamp":1632351048000},"page":"1760","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Experimental Validation of a Mathematical Model to Describe the Drug Cytotoxicity of Leukemic Cells"],"prefix":"10.3390","volume":"13","author":[{"given":"Ekaterina","family":"Guzev","sequence":"first","affiliation":[{"name":"Department of Mathematics, Ariel University, Ariel 4070000, Israel"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-3989","authenticated-orcid":false,"given":"Galia","family":"Luboshits","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, Ariel University, Ariel 4070000, Israel"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5280-3217","authenticated-orcid":false,"given":"Svetlana","family":"Bunimovich-Mendrazitsky","sequence":"additional","affiliation":[{"name":"Department of Mathematics, Ariel University, Ariel 4070000, Israel"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8430-0486","authenticated-orcid":false,"given":"Michael A.","family":"Firer","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, Ariel University, Ariel 4070000, Israel"},{"name":"Adelson School of Medicine, Ariel University, Ariel 4070000, Israel"},{"name":"Ariel Center for Applied Cancer Research, Ariel University, Ariel 4070000, Israel"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1172\/JCI64101","article-title":"Molecular pathogenesis of chronic lymphocytic leukemia","volume":"122","author":"Gaidano","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_2","unstructured":"Burger, J.A. (2020, July 30). Treatment of Chronic Lymphocytic Leukemia, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/32726532\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11912-019-0778-2","article-title":"Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma","volume":"21","author":"Huang","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/cncr.31931","article-title":"Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options","volume":"125","author":"Sharma","year":"2019","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41408-018-0131-2","article-title":"Chronic lymphocytic leukemia treatment algorithm 2018","volume":"8","author":"Parikh","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3934\/dcdsb.2004.4.147","article-title":"A hierarchy of cancer models and their mathematical challenges","volume":"4","author":"Friedman","year":"2004","journal-title":"Discret. Contin. Dyn. Syst. Ser. B"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1088\/0951-7715\/23\/1\/R01","article-title":"Nonlinear modeling of cancer: Bridging the gap between cells and tumours","volume":"23","author":"Lowengrub","year":"2009","journal-title":"Nonlinearity"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrc4029","article-title":"The mathematics of cancer: Integrating quantitative models","volume":"15","author":"Altrock","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2015.11.002","article-title":"Improving cancer treatment via mathematical modeling: Surmounting the challenges is worth the effort","volume":"163","author":"Michor","year":"2015","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bulm.2003.11.002","article-title":"A history of the study of solid tumour growth: The contribution of mathematical modeling","volume":"66","author":"Araujo","year":"2004","journal-title":"Bull. Math. Biol."},{"key":"ref_11","first-page":"25","article-title":"Mathematical model of T-cell lymphoblastic lymphoma: Disease, treatment, cure or relapse of a virtual cohort of patients","volume":"35","author":"Eymard","year":"2018","journal-title":"Math. Med. Biol. A J. IMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s10957-015-0717-9","article-title":"Stability and controllability issues in mathematical modeling of the intensive treatment of leukemia","volume":"167","author":"Berezansky","year":"2015","journal-title":"J. Optim. Theory Appl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1158\/1078-0432.CCR-15-2793","article-title":"Myeloma cell dynamics in response to treatment supports a model of hierarchical differentiation and clonal evolution","volume":"22","author":"Tang","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1137\/100815517","article-title":"Hybrid model of erythropoiesis and leukemia treatment with cytosine arabinoside","volume":"71","author":"Kurbatova","year":"2011","journal-title":"SIAM J. Appl. Math."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-3083.2003.01331.x","article-title":"Prolegomenon for chronic lymphocytic leukaemia","volume":"58","author":"Vitale","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"ref_16","first-page":"445","article-title":"Mathematical model of B-cell chronic lymphocytic leukemia (CLL)","volume":"107","author":"Martinis","year":"2005","journal-title":"Period. Biol."},{"key":"ref_17","first-page":"1053","article-title":"B cell chronic lymphocytic leukemia-a model with immune response","volume":"18","author":"Nanda","year":"2013","journal-title":"Discret. Contin. Dyn. Syst. B"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02460644","article-title":"Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis","volume":"56","author":"Kuznetsov","year":"1994","journal-title":"Bull. Math. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells","volume":"115","author":"Messmer","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Axenie, C., and Kurz, D. (2020). CHIMERA: Combining Mechanistic Models and Machine Learning for Personalized Chemotherapy and Surgery Sequencing in Breast Cancer. International Symposium on Mathematical and Computational Oncology, Springer.","DOI":"10.1101\/2020.06.08.140756"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11095-018-2562-7","article-title":"Machine learning models for the prediction of chemotherapy-induced peripheral neuropathy","volume":"36","author":"Bloomingdale","year":"2019","journal-title":"Pharm. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1573409914666180525124608","article-title":"The application of machine learning techniques in clinical drug therapy","volume":"15","author":"Meng","year":"2019","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"ref_23","first-page":"118","article-title":"A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia","volume":"349","author":"Rodrigues","year":"2019","journal-title":"Appl. Math. Comput."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/10428199609054821","article-title":"Chlorambucil in Chronic Lymphocytic Leukemia: Mechanism of Action","volume":"23","author":"Begleiter","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.1995.13.7.1786","article-title":"High-dose intravenous melphalan: A review","volume":"13","author":"Samuels","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"ref_26","unstructured":"Faruqi, A., and Tadi, P. (2020). Cytarabine. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Weinberg, R.A. (2013). The Biology of Cancer, Garland Science.","DOI":"10.1201\/9780429258794"},{"key":"ref_28","unstructured":"L\u00fcllmann, H., Mohr, K., Hein, L., and Bieger, D. (2000). Color Atlas of Pharmacology, Thieme."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10616-010-9274-0","article-title":"Cell death in mammalian cell culture: Molecular mechanisms and cell line engineering strategies","volume":"62","author":"Krampe","year":"2010","journal-title":"Cytotechnology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep04698","article-title":"Cell death stages in single apoptotic and necrotic cells monitored by Raman microspectroscopy","volume":"4","author":"Brauchle","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_31","first-page":"1017","article-title":"Cell death. A comprehensive approximation. Necrosis","volume":"1","author":"Alvarez","year":"2010","journal-title":"Microsc. Sci. Technol. Appl. Educ."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bellman, R. (1983). Mathematical Methods in Medicine, World Scientific.","DOI":"10.1142\/0028"},{"key":"ref_33","first-page":"1","article-title":"Experimental evaluation of potential anticancer agents. xiii. on the criteria and kinetics associated with \u201ccurability\u201d of experimental leukemia","volume":"35","author":"Skipper","year":"1964","journal-title":"Cancer Chemother. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0025-5564(73)90072-2","article-title":"Tumor growth and chemotherapy: Mathematical methods, computer simulations, and experimental foundations","volume":"17","author":"Aroesty","year":"1973","journal-title":"Math. Biosci."}],"container-title":["Symmetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-8994\/13\/10\/1760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:03:12Z","timestamp":1760166192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-8994\/13\/10\/1760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["sym13101760"],"URL":"https:\/\/doi.org\/10.3390\/sym13101760","relation":{},"ISSN":["2073-8994"],"issn-type":[{"type":"electronic","value":"2073-8994"}],"subject":[],"published":{"date-parts":[[2021,9,22]]}}}